Drug Master Files for: 3d Imaging Drug
✉ Email this page to a colleague
3d Imaging Drug Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
24014 | A | II | 7/23/2010 | 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC | [I-124] FIAU (FIALURIDINE) |
24168 | I | II | 9/15/2010 | 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC | [F-18] FDPN |
25853 | A | II | 3/23/2012 | 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC | SODIUM IODIDE I 124 |
27297 | A | II | 7/19/2013 | 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC | FLUOROMISONIDAZOLE F 18 INJECTION |
27301 | A | II | 10/1/2013 | 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC | DPA-713 I 124 INJECTION |
27628 | I | II | 12/27/2013 | 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC | [I-124]CLR1404 INJECTION |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information